Edward W. Gregg, PhD, Receives American Diabetes Association's Kelly West Award for Outstanding Achievement in Epidemiology


Michelle Kirkwood

Alexandria, Virginia
May 31, 2016

Edward W. Gregg, PhD, is the recipient of the American Diabetes Association's 2016 Kelly West Award for Outstanding Achievement in Epidemiology. This award recognizes significant contributions to the field of diabetes epidemiology. Gregg will be recognized with this honor during the Association's 76th Scientific Sessions®, June 10-14, 2016, at the Ernest N. Morial Convention Center in New Orleans. He will deliver the Kelly West Award Lecture, titled "The Changing Tides of the Diabetes Epidemic—Smooth Sailing or Troubled Waters Ahead?," on Sunday, June 12.

Gregg, Captain in the U.S. Public Health Service, is Chief of the Epidemiology and Statistics Branch in the Division of Diabetes Translation at the Centers for Disease Control and Prevention (CDC). In his CDC role, he leads multidisciplinary teams that integrate surveillance, epidemiology, statistics, health services research and economic studies to guide health policy for diabetes. Recognized nationally and internationally for extensive contributions to diabetes epidemiology, Gregg has provided guidance and expertise to numerous studies and organizations and committees. His work, described in more than 240 published articles and book chapters, documents diabetes statistics in the U.S. and the lifetime risk and cost of diabetes. Furthermore, it reports the decline of many complications of diabetes, the achievement of diabetes care goals, and the impact of lifestyle intervention on risk for diabetes and its complications. This extensive body of work has significantly impacted public health research and policy and strengthened national and international surveillance of diabetes.

"Congratulations Dr. Gregg, and thank you for your exceptional contributions to diabetes epidemiology," said Margaret A. Powers, PhD, RD, CDE, President, Health Care & Education for the American Diabetes Association. "Your research efforts in the field of diabetes epidemiology have been an invaluable guide in health policy efforts for people with diabetes."

The Kelly West Award for Outstanding Achievement in Epidemiology is supported by an unrestricted educational grant from Merck.

The American Diabetes Association's 76th Scientific Sessions, to be held June 10-14, 2016, at the Ernest N. Morial Convention Center in New Orleans, is the world's largest scientific meeting focused on diabetes. The 2016 Scientific Sessions is expected to attract more than 16,000 attendees, and offers researchers and health care professionals from around the world the opportunity to share ideas and learn about the significant advances in diabetes research, treatment and care. During the five-day meeting, attendees receive exclusive access to more than 2,500 original research presentations, participate in provocative and engaging exchanges with leading diabetes experts, and can earn Continuing Medical Education (CME) or Continuing Education (CE) credits for educational sessions. The program is grouped into eight theme areas: Acute and Chronic Complications; Behavioral Medicine, Clinical Nutrition, Education and Exercise; Clinical Diabetes/Therapeutics; Epidemiology/Genetics; Immunology/Transplantation; Insulin Action/Molecular Metabolism; Integrated Physiology/Obesity; and Islet Biology/Insulin Secretion. Margaret A. Powers, PhD, RD, CDE, President, Health Care & Education, will deliver her address on Saturday, June 11, and Desmond Schatz, MD, President, Medicine & Science, will present his address on Sunday, June 12. The top eight abstracts of this year's Scientific Sessions will be presented on Tuesday, June 14, in the Presidents Oral Session. In total, the 2016 Scientific Sessions includes 378 abstracts in 50 oral sessions, 2,021 poster presentations including 59 moderated poster discussions, and 335 published-only abstracts. Additional scientific research will be presented during 110 Symposia and 9 Professional Interest Group sessions. The 76th Scientific Sessions also includes presence from more than 130 corporate and organizational exhibitors in nearly 100,000 square feet of exhibit space.

About the American Diabetes Association

Nearly half of American adults have diabetes or prediabetes; more than 30 million adults and children have diabetes; and every 21 seconds, another individual is diagnosed with diabetes in the U.S. Founded in 1940, the American Diabetes Association (ADA) is the nation’s leading voluntary health organization whose mission is to prevent and cure diabetes, and to improve the lives of all people affected by diabetes. The ADA drives discovery by funding research to treat, manage and prevent all types of diabetes, as well as to search for cures; raises voice to the urgency of the diabetes epidemic; and works to safeguard policies and programs that protect people with diabetes. In addition, the ADA supports people living with diabetes, those at risk of developing diabetes, and the health care professionals who serve them through information and programs that can improve health outcomes and quality of life. For more information, please call the ADA at 1-800-DIABETES (1-800-342-2383) or visit diabetes.org. Information from both of these sources is available in English and Spanish. Find us on Facebook (American Diabetes Association), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn)